KLF2 and cancer: Furthermore, KLF2, as an ERK5 downstream target, could be implicated in cancer through different mechanisms that remain unexplored, as could be the case of stem cell biology [65,66] or other processes such as inflammatory response [67], immune response [68], or angiogenesis [61,69].